ketoconazole has been researched along with Vomiting in 5 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 7.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| "The effectiveness and safety of treatment with ketoconazole and itraconazole were compared in 773 sporotrichosis-infected cats over a four-year period (2002 to 2005)." | 5.14 | Response to azolic antifungal agents for treating feline sporotrichosis. ( Figueiredo, FB; Gremião, ID; Monteiro, PC; Passos, SR; Pereira, SA; Schubach, TM; Silva, JN; Teixeira, JL, 2010) |
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 3.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| " One additional cat failed to improve initially, but complete resolution was achieved after the dosage of ketoconazole was doubled." | 1.28 | Ketoconazole for treatment of dermatophytosis in cats. ( Chalmers, SA; Medleau, L, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karniadakis, I | 1 |
| Garoufalia, Z | 1 |
| Kouskos, E | 1 |
| Mantas, D | 1 |
| Pereira, SA | 1 |
| Passos, SR | 1 |
| Silva, JN | 1 |
| Gremião, ID | 1 |
| Figueiredo, FB | 1 |
| Teixeira, JL | 1 |
| Monteiro, PC | 1 |
| Schubach, TM | 1 |
| Dismukes, WE | 2 |
| Stamm, AM | 2 |
| Graybill, JR | 1 |
| Craven, PC | 1 |
| Stevens, DA | 1 |
| Stiller, RL | 1 |
| Sarosi, GA | 1 |
| Medoff, G | 1 |
| Gregg, CR | 1 |
| Gallis, HA | 1 |
| Fields, BT | 1 |
| Marier, RL | 1 |
| Kerkering, TA | 1 |
| Kaplowitz, LG | 1 |
| Cloud, G | 1 |
| Bowles, C | 1 |
| Shadomy, S | 1 |
| Medleau, L | 1 |
| Chalmers, SA | 1 |
1 review available for ketoconazole and Vomiting
| Article | Year |
|---|---|
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
1 trial available for ketoconazole and Vomiting
| Article | Year |
|---|---|
Response to azolic antifungal agents for treating feline sporotrichosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Appetite; Cat Diseases; Cats; Diarrhea; Female; It | 2010 |
3 other studies available for ketoconazole and Vomiting
| Article | Year |
|---|---|
Pancreatic adenocarcinoma presenting with Cushing's syndrome.
Topics: 14-alpha Demethylase Inhibitors; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Diagnosis, Dif | 2021 |
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Child; Child, Preschool; Drug Evaluation; Huma | 1983 |
Ketoconazole for treatment of dermatophytosis in cats.
Topics: Animals; Anorexia; Cat Diseases; Cats; Dermatomycoses; Diarrhea; Female; Ketoconazole; Male; Vomitin | 1992 |